Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
13734-38-8
1807503-91-8
1807540-85-7
2055023-35-1
2055042-61-8
135311-97-6 | 6,7-Dihydroisoquinolin-8(5h)-one hydrochloride | AA009WGX | MFCD18432614
1415566-28-7 | 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | AA009WM3 | MFCD31654721
1355246-90-0 | Methyl 1-cyclopentylbenzimidazole-5-carboxylate | AA009WQ4 | MFCD21332962
1329399-10-1 | 3-Bromo-N-cyclopentyl-5-fluorobenzamide | AA009WTH | MFCD21369418
1262006-39-2 | 5-(4-Chloro-3-methylphenyl)-6-hydroxynicotinic acid | AA009WXR | MFCD18317651
143425-48-3 | 3-(4-Methylphenyl)pyridine-2-carbonitrile | AA009X1T | MFCD22586704
1423037-24-4 | Methyl 4-amino-3-(isopropylamino)benzoate | AA009X54 | MFCD23135900
1380300-42-4 | (5-Chloropyridin-3-yl)methanamine dihydrochloride | AA009XGG | MFCD22375703
1258780-50-5 | 9-Phenyl-3,6-bis[4-(1-phenyl-1H-benzimidazol-2-yl)phenyl]-9H-carbazole | AA009Y27 | MFCD31618148
1364699-31-9 | 4-(1-(3-bromophenyl)ethyl)morpholine | AA009YFM | MFCD23554997